Harm Wienbergen
Overview
Explore the profile of Harm Wienbergen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wienbergen H, Boakye D, Gunther K, Schmucker J, Marin L, Kerniss H, et al.
Eur J Prev Cardiol
. 2022 Jul;
29(16):2076-2087.
PMID: 35776839
Aims: Family history is a known risk factor for early-onset myocardial infarction (EOMI). However, the role of modifiable lifestyle and metabolic factors in EOMI risk is unclear and may differ...
12.
Poss J, Sinning C, Schreiner I, Apfelbacher C, Drewitz K, Hosler N, et al.
Clin Res Cardiol
. 2022 Jun;
112(4):455-463.
PMID: 35729429
Background: In Germany, 70,000-100,000 persons per year suffer from out-of-hospital cardiac arrest (OHCA). Despite medical progress, survival rates with good neurological outcome remain low. For many important clinical issues, no...
13.
14.
Schmucker J, Fach A, Osteresch R, Marin L, Retzlaff T, Ruhle S, et al.
BMC Cardiovasc Disord
. 2022 Apr;
22(1):142.
PMID: 35365074
Background: Although the detrimental effects of advanced chronic kidney disease (CKD) on prognosis in coronary artery disease is known, there are few data on the efficacy and safety of modern...
15.
Zeymer U, Toelg R, Wienbergen H, Hobbach H, Cuneo A, Bekeredjian R, et al.
Herz
. 2022 Mar;
48(2):134-140.
PMID: 35243515
Background: Little is known about current patterns of antithrombotic therapy in patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in clinical practice in Germany. Methods: The RIVA-PCI is...
16.
Osteresch R, Diehl K, Dierks P, Schmucker J, Ammar A, Marin L, et al.
Int J Cardiol Heart Vasc
. 2021 Nov;
37:100903.
PMID: 34805479
Background: It is important to identify further predictors of outcome after successful transcatheter mitral valve repair (TMVR), as optimal patient selection remains difficult. Objective: The study investigates the prognostic benefit...
17.
Schmucker J, Fach A, Osteresch R, Marin L, Ruehle S, Retzlaff T, et al.
J Cardiovasc Dev Dis
. 2021 Aug;
8(8).
PMID: 34436225
Background: Diabetic patients show higher adverse ischemic event rates and mortality when undergoing percutaneous coronary intervention (PCI) in acute myocardial infarctions. Therefore, diabetic patients might benefit even more from modern-generation...
18.
Osteresch R, Fach A, Frielitz F, Meyer S, Schmucker J, Ruhle S, et al.
Am J Cardiol
. 2021 Jul;
154:7-13.
PMID: 34238446
Effective long-term prevention after myocardial infarction (MI) is crucial to reduce recurrent events. In this study the effects of a 12-months intensive prevention program (IPP), based on repetitive contacts between...
19.
Marin L, Schmucker J, Fach A, Osteresch R, Ruhle S, Garstka D, et al.
Clin Res Cardiol
. 2021 Jul;
110(10):1647-1658.
PMID: 34216252
Background: Only few data on the prevalence of DM in young patients with ST-elevation myocardial infarction (STEMI) exist. Aim of the present study was to analyse this prevalence, its association...
20.
Wienbergen H, Retzlaff T, Schmucker J, Marin L, Ruhle S, Garstka D, et al.
Am J Cardiol
. 2021 May;
151:10-14.
PMID: 34049671
Impact of COVID-19 pandemic and pandemic-related social restrictions on clinical course of patients treated for acute ST-elevation myocardial infarction (STEMI) is unclear. In the present study presentation and outcome of...